Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
SB1518(Pacritinib) cas:937272-79-2
SB1518(Pacritinib)
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-675 | 50mg | 260.00 | + Add to cart |
|
| R-C-675 | 100mg | 445.00 | + Add to cart |
|
| R-C-675 | 200mg | 730.00 | + Add to cart |
|
|
|
||||
Product description
Pacritinib,also known as SB1518,is an orally bioavailable inhibitor of Janus kinase 2(JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity.Pacritinib competes with JAK2 for ATP binding,which may result in inhibition of JAK2 activation,inhibition of the JAK-STAT signaling pathway, and so caspase-dependent apoptosis.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| Purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | DMSO |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds---SB1518(Pacritinib) Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
